Promoter methylation of genes in bronchial lavages: A marker for early diagnosis of primary and relapsing non-small cell lung cancer?
Promoter methylation of genes in bronchial lavages: A marker for early diagnosis of primary and relapsing non-small cell lung cancer?
复制标题
DOI:
10.1016/j.lungcan.2005.05.019
复制
发表时间:
2005-11-01
期刊:
影响因子:
5.3
通讯作者:
Favrot, MC
中科院分区:
文献类型:
--
作者:
de Fraipont, F;Moro-Sibilot, D;Favrot, MC
A prospective screening program, including CT, autofluorescent bronchoscopy, biopsies and bronchial lavage (BL) collection, was initiated with the specific goal of identifying biomarkers for the early detection of non-small cell lung cancer. We report and discuss the results of p16, DAPK, MGMT, FHIT and APC methytation analysis in the 126 first patients: 77 at high risk of cancer and 49 followed up after primary cancer resection.Positive results were found in 49% of BLs, 53% in current smokers and 43% in former smokers. In presence of peripheral tumours, only 38% of BLs were abnormal versus 73% in presence of central tumours, 50% in presence of preneoplasic lesions and 47% in absence of lesions. FHIT methytation was an early event, observed in one-third of the BLs from patients with or without lesions as well as in tumours. APC methylation was a late event observed in 33% of tumours but rarely in BLs. p16 was methylated in 17% of BLs but in 48% of tumours; DAPK in 15% of BL and 22% of tumours. MGMT methylation was rare. Among patients followed up after, cancer surgery, 14 were in remission with normalised BL, whereas three had positive BLs. and relapsed with a central tumour.Thus, gene methylation in BL might help to detect central tumors but a CT is crucial for peripheral cancer detection. (c) 2005 Elsevier Ireland Ltd. All rights reserved.